3,863
Views
3
CrossRef citations to date
0
Altmetric
Case Report

Successful treatment of canine infective endocarditis caused by Bacillus amyloliquefaciens

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 41-47 | Received 04 Nov 2020, Accepted 21 Jan 2022, Published online: 11 Feb 2022

References

  • Bae J, Kim H, Kim W, Kim S, Park J, Jung DI, Yu D. 2019. Therapeutic monitoring of rivaroxaban in dogs using thromboelastography and prothrombin time. J Vet Intern Med. 33(3):1322–1330.
  • Brouqui P, Raoult D. 2001. Endocarditis due to rare and fastidious bacteria. Clin Microbiol Rev. 14(1):177–207.
  • Burgueño JF, Abreu MT. 2020. Epithelial Toll-like receptors and their role in gut homeostasis and disease. Nat Rev Gastroenterol Hepatol. 17(5):263–278.
  • Buyukasyk NS, Ileri M, Alper A, Senen K, Atak R, Hisar I, Yetkin E, Turhan H, Demirkan D. 2004. Increased blood coagulation and platelet activation in patients with infective endocarditis and embolic events. Clin Cardiol. 27(3):154–158.
  • Costa RL, Moreira J, Lorenzo A, Lamas CC. 2018. Infectious complications following probiotic ingestion: a potentially underestimated problem? A systematic review of reports and case series. BMC Complement Altern Med. 18(1):329.
  • Elshaghabee FM, Rokana N, Gulhane RD, Sharma C, Panwar H. 2017. Bacillus as potential probiotics: status, concerns, and future perspectives. Front Microbiol. 8:1490.
  • Fabri J, Jr., Issa VS, Pomerantzeff PM, Grinberg M, Barretto AC, Mansur AJ. 2006. Time-related distribution, risk factors and prognostic influence of embolism in patients with left-sided infective endocarditis. Int J Cardiol. 110(3):334–339.
  • Fuentes L, Johnson LR, Dennis S. 2010. BSAVA Manual of canine and feline cardiorespiratory medicine. Gloucester (UK): British Small Animal Veterinary Association.
  • Gagnon AL, Scansen BA, Olver C, Shropshire S, Hess A, Orton EC. 2021. Phase I clinical trial of an antithrombotic drug protocol combining apixaban and clopidogrel in dogs. J Vet Cardiol. 36:105–114.
  • Gopal N, Hill C, Ross PR, Beresford TP, Fenelon MA, Cotter PD. 2015. The prevalence and control of Bacillus and related spore-forming bacteria in the dairy industry. Front Microbiol. 6:1418.
  • Hong HA, Duc LH, Cutting SM. 2005. The use of bacterial spore formers as probiotics. FEMS Microbiol Rev. 29(4):813–835.
  • Le T, Bayer AS. 2003. Combination antibiotic therapy for infective endocarditis. Clin Infect Dis. 36(5):615–621.
  • Lee A, Cheng K-C, Liu J-R. 2017. Isolation and characterization of a Bacillus amyloliquefaciens strain with zearalenone removal ability and its probiotic potential. PLoS One. 12(8):e0182220.
  • Lo ST, Walker AL, Georges CJ, Li RH, Stern JA. 2021. Dual therapy with clopidogrel and rivaroxaban in cats with thromboembolic disease. J Feline Med Surg. 2021:1098612X2110137.
  • Macdonald K. 2010. Infective endocarditis in dogs: diagnosis and therapy. Vet Clin North Am Small Anim Pract. 40(4):665–684.
  • Macdonald KA. 2014. Infective endocarditis. In: Cote’s Clinical Veterinary Advisor: Dogs and Cats. 3rd ed. Philadelphia (PA): Saunders, Elsevier Inc. p. e291–e299.
  • Micol R, Lortholary O, Jaureguy F, Bonacorsi S, Bingen E, Lefort A, Memain N, Bouchaud O, Larroche C. 2006. Escherichia coli native valve endocarditis. Clin Microbiol Infect. 12(5):401–403.
  • Miller MW, Fox PR, Saunders AB. 2004. Pathologic and clinical features of infectious endocarditis. J Vet Cardiol. 6(2):35–43.
  • Mocan M, Mocan Hognogi LD, Anton FP, Chiorescu RM, Goidescu CM, Stoia MA, Farcas AD. 2019. Biomarkers of inflammation in left ventricular diastolic dysfunction. Dis Markers. 2019:1–14.
  • Norgate D, Bruniges N. 2016. Suspected anaphylaxis following intravenous amoxicillin clavulanate administration under general anaesthesia in nine dogs. Vet Rec Case Rep. 4:e000295.
  • Oggioni MR, Pozzi G, Valensin PE, Galieni P, Bigazzi C. 1998. Recurrent septicemia in an immunocompromised patient due to probiotic strains of Bacillus subtilis. J Clin Microbiol. 36(1):325–326.
  • Peddle G, Sleeper MM. 2007. Canine bacterial endocarditis: a review. J Am Anim Hosp Assoc. 43(5):258–263.
  • Peddle GD, Drobatz KJ, Harvey CE, Adams A, Sleeper MM. 2009. Association of periodontal disease, oral procedures, and other clinical findings with bacterial endocarditis in dogs. J Am Vet Med Assoc. 234(1):100–107.
  • Ravine T. 2019. Bacillus: An environmental contaminant or misunderstood pathogen? J Bacteriol Mycol. 6:1117.
  • Sorokulova I. 2013. Modern status and perspectives of Bacillus bacteria as probiotics. J Prob Health. 1(4):2.
  • Sykes JE, Kittleson MD, Chomel BB, Macdonald KA, Pesavento PA. 2006. Clinicopathologic findings and outcome in dogs with infective endocarditis: 71 cases (1992-2005). J Am Vet Med Assoc. 228(11):1735–1747.
  • Sykes JE, Kittleson MD, Pesavento PA, Byrne BA, MacDonald KA, Chomel BB. 2006. Evaluation of the relationship between causative organisms and clinical characteristics of infective endocarditis in dogs: 71 cases (1992–2005). J Am Vet Med Assoc. 228(11):1723–1734.
  • Thuny F, Grisoli D, Collart F, Habib G, Raoult D. 2012. Management of infective endocarditis: challenges and perspectives. Lancet. 379(9819):965–975.
  • Villiers E, Ristić J. 2016. BSAVA manual of canine and feline clinical pathology. Gloucester (UK): British Small Animal Veterinary Association.
  • Vogkou CT, Vlachogiannis NI, Palaiodimos L, Kousoulis AA. 2016. The causative agents in infective endocarditis: a systematic review comprising 33,214 cases. Eur J Clin Microbiol Infect Dis. 35(8):1227–1245.
  • Willard MD, Tvedten H. 2011. Small animal clinical diagnosis by laboratory methods [e-book]. Amsterdam (the Netherlands): Elsevier Health Sciences.
  • Yelin I, Flett KB, Merakou C, Mehrotra P, Stam J, Snesrud E, Hinkle M, Lesho E, McGann P, McAdam AJ, et al. 2019. Genomic and epidemiological evidence of bacterial transmission from probiotic capsule to blood in ICU patients. Nat Med. 25(11):1728–1732.